ID   RSp
AC   CVCL_M628
SY   RSP
DR   Wikidata; Q54951340
RX   PubMed=78764;
RX   PubMed=12592342;
RX   PubMed=29533902;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT23 ! RN
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
RX   PubMed=78764;
RA   Friend C., Marovitz W., Henie G., Henie W., Tsuei D., Hirschhorn K.,
RA   Holland J.G., Cuttner J.;
RT   "Observations on cell lines derived from a patient with Hodgkin's
RT   disease.";
RL   Cancer Res. 38:2581-2591(1978).
//
RX   PubMed=12592342; DOI=10.1038/sj.leu.2402799;
RA   Drexler H.G., Dirks W.G., Matsuo Y., MacLeod R.A.F.;
RT   "False leukemia-lymphoma cell lines: an update on over 500 cell
RT   lines.";
RL   Leukemia 17:416-426(2003).
//
RX   PubMed=29533902; DOI=10.1515/hsz-2017-0321;
RA   Drexler H.G., Pommerenke C., Eberth S., Nagel S.;
RT   "Hodgkin lymphoma cell lines: to separate the wheat from the chaff.";
RL   Biol. Chem. 399:511-523(2018).
//